J&J Shares Decline Following $4.69 Billion Asbestos Talc Verdict

July 13, 2018, 1:45 PM UTC

Johnson & Johnson fell after a jury ordered the company to pay $4.69 billion to women who claimed asbestos in the company’s talc products caused them to develop ovarian cancer, marking the sixth-largest product-defect verdict in U.S. history.

The award of $4.14 billion in punitive damages and $550 million to compensate 22 women and their families for their losses sent shares of the health-care and consumer-products giant down 1.9 percent to $125.28 at 8:03 a.m. in premarket trading on Friday in New York.

The verdict Thursday by jurors in St. Louis city court came in the first test of plaintiffs’ ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.